期刊文献+

外质体(Exosomes)与肾脏疾病 被引量:2

Exosomes and kidney diseases
下载PDF
导出
摘要 外质体(Exosomes)是起源于多泡体的微小囊泡,由细胞内吞途径中的多泡体外膜和细胞膜融合后释放到胞外环境或体液中。Exosomes含有多种蛋白、mRNAs、microRNAs、信号分子等,能够反映来源细胞的生物学状态,因而可能成为潜在的生物学标志物。目前,exosomes的研究大多集中在免疫学和肿瘤学,并已经成为一种免疫治疗的新手段,应用于肿瘤治疗和免疫耐受等方面。近年人们才关注exosomes与肾脏疾病的关系,研究表明几乎所有肾脏上皮细胞包括肾小球足细胞、肾小管上皮细胞、尿道上皮细胞均可分泌exosomes,因此尿液来源的exosomes可能成为寻找肾脏疾病早期诊断的标志物。本文着重从exosomes的生物学特性及其在肾脏疾病诊断和治疗的研究进行综述。 Exosomes are nanovesicles originating from multivesicular bodies (MVBs) and secreted into the extracellular space or body fluids when a multivesicular body (endocytic origin) fuses with the plasma membrane. Exosomes contain multiple proteins, mRNAs, microRNAs, and signaling molecules that may reflect the physiological state of their cells of origin and consequently provide potential biomarkers. At present ,the studies on exosomes are mostly focused on their roles in immunology and oncology and exosome-based immunotherapy has become a new means in cancer treatment and immune tolerance. In recent years,urinary exosomes (UE) and their roles in kidney diseases have been receiving great attention. Exosomes are secreted to the urine from all types of renal epithelial cell, including glomerular podocytes, renal tubular cells, and the cells lining the urinary drainage system. Thus, urinary exosomes have potential as a source of valuable biomarkers for early detection of kidney diseases. The present review aims to summarize their biological characteristics, and their potential uses in the diagnosis and treatment of kidney disease.
作者 柏云 郑春霞
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2012年第4期370-374,383,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 外质体 肾脏疾病尿液生物标记物 exosomes kidney disease urinary biomakers
  • 相关文献

参考文献33

  • 1Trams EG, Lauter C J, Salem N Jr, et al. Exfoliation of membrane ecto- enzymes in the form of micro-vesicles. Biochim Biophys Acta, 1981, 645( 1 ) :63 -70.
  • 2Johnstone RM, Adam M, Hammond JR, et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles ( exosomes ). J Biol Chem, 1987,262 ( 19 ) : 9412 - 9420.
  • 3Camussi G, Deregibus MC, Bruno S, et al. Exosomes/microvesieles as a mechanism of cell-to-cell communication. Kidney Int ,2010,78 (9) : 838 - 848.
  • 4Johnstone RM. Exosomes biological siguifieance: A concise review. Blood Cells Mol Dis,2006,36(2) :315 -321.
  • 5Futter CE, Peame A, Hewlett LJ, et al. Multivesieular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J Cell Bio1,1996,132(6) :1011 -1023.
  • 6Kleijmeer M, Ramm G, Schuurhuis D, et al. Reorganization of muhivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol,2001,155( 1 ) :53 -63.
  • 7van Niel G, Porto-Carreiro 1, Simoes S, et 82. Exosomes: a common pathway for a specialized function. J Biochem, 2006, 140 (1):13-21.
  • 8Wollert T, Hurley JH. Molecular mechanism of muhivesicular body biogenesis by ESCRT complexes. Nature, 2010, 464 (7290) :864 - 869.
  • 9Stoorvogel W, Kleijmeer MJ, Geuze HJ, et al. The biogenesis and functions of exosomes. Traffic ,2002,3 (5) :321 - 330.
  • 10Th6ry C, Zitvogel L, Amigorena S. Exosomes : composition, biogenesis and function. Nat Rev Immunol,2002,2 (8) :569 -579.

同被引文献48

  • 1Singh PP, Smith VL, Karakousis PC, et al. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo[J].J Immunol, 2012, 189(2): 777 -785.
  • 2Masyuk AI, Huang BQ, Ward CJ, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through inter?action with primary cilia[J]. AmJ Physiol Gastrointest Liver Physiol, 2010, 299( 4) : G990 - G999.
  • 3Ogawa Y, Miura Y, Harazono A, et al. Proteomic analysis of two types of exosomes in human whole saliva[J]. BioI Pharm Bull, 2011 , 34 (l) : 13 - 23 .
  • 4DearJW, StreetJM, Bailey MA. Urinary exosomes , a reservoir for biomarker discovery and potential mediators of intrarenal signalling[J]. Proteomics, 2013, 13 (10 - 11): 1572 - 1580.
  • 5Ghayad SE, Cohen PA. Inhibitors of the PI3K1AktimTOR pathway: new hope for breast cancer patients[J]. Recent Pat Anticancer Drug Discov, 2010, 5 (1) : 29 - 57 .
  • 6Filipazzi P, Burdek M, Villa A, et al. Recent advances on the role of tumor exosomes in immunosuppression and disease progression[Jl. Semin Cancer BioI, 2012, 22 (4) : 342 - 349.
  • 7Moon PG, You S, LeeJE, et al. Urinary exosomes and proteomics[Jl. Mass Spectrom Rev, 2011 , 30 (6) : 1185 - 1202.
  • 8Fang DY, King HW, LiJY, et al. Exosomes and the kidney: blaming the messenger[J]. Nephrology (Carlton) , 2013, 18 ( 1) : 1 -10.
  • 9van Balkom BW, Pisitkun T, Verhaar MC, et al. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases[J] . Kidney Int, 2011, 80( 11): 1138 -1145.
  • 10Miranda KC, Bond DT, Mekee M, et al. Nucleic acids within urinary exosomesl microvesicles are potential biomarkers for renal diseasej L]: Kidney Int, 2010, 78(2): 191 -199.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部